Earlier this week, the FTC announced settlement of one of the few “Made in USA” cases the agency has litigated in recent years.
“…Clowns to the right of me, jokers to the left, here I am…” – Stealers Wheel (1972)
How much trust do you place in celebrities who endorse products on social media platforms such as Instagram, Snapchat, Facebook, Twitter, and YouTube?
On October 6, Federal Communications Commission Chairman Tom Wheeler published a fact sheet and blog post outlining his proposal to create privacy rules for internet service providers (ISPs), setting the final rules up for a vote at the FCC’s October 27 open meeting.
In pharmaceutical transactions involving generic products, the Federal Trade Commission (FTC) has typically focused on narrow antitrust theories of harm and applied a narrow product market analysis often limited to a treatment for a particular indication (and sometimes to a specific mechanism of action).
We wrote previously about the FTC’s efforts to hold an affiliate network (LeadClick) and that network’s successor (CoreLogic) responsible for their role in working with LeanSpa, a marketer of dietary supplements.
Second Circuit Holds Marketing Campaign Organizer Liable Under FTC Act for Deceptive Representations of Its Marketing “Affiliates”
There is nothing new about the FTC bringing enforcement actions based on deceptive advertising practices.
Yesterday, the U.S. Federal Trade Commission (“FTC”) released a 269-page Report following its study of patent assertion entities (“PAEs”) — i.e. what the FTC’s press release calls “firms that acquire patents from third parties and then try to make money by licensing or suing accused infringers.”
With the end of summer and the start of school also comes the fall advertising law conference season, starting with the annual NAD conference.
Last week, the European Data Protection Supervisor (the “EDPS”), in collaboration with European consumer organisation BEUC, hosted a joint conference on Big Data: individual rights and smart enforcement in Brussels (for the conference agenda, see here).